Bausch Health/$BHC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Bausch Health
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
Ticker
$BHC
Sector
Trading on
NYSE
Industry
Pharmaceuticals
Headquarters
Laval, Canada
Employees
20,700
ISIN
CA0717341071
Website
Bausch Health Metrics
BasicAdvanced
$1.7B
-
-$0.11
0.43
-
Price and volume
Market cap
$1.7B
Beta
0.43
52-week high
$9.49
52-week low
$3.96
Average daily volume
1.6M
Financial strength
Current ratio
1.347
Quick ratio
0.753
Long term debt to equity
-8,845
Total debt to equity
-6,782.298
Interest coverage (TTM)
1.36%
Management effectiveness
Return on assets (TTM)
4.31%
Return on equity (TTM)
39.13%
Valuation
Price to revenue (TTM)
0.174
Price to book
-1.33
Price to tangible book (TTM)
-0.1
Price to free cash flow (TTM)
1.407
Growth
Revenue change (TTM)
8.53%
Earnings per share change (TTM)
-91.28%
3-year revenue growth (CAGR)
5.34%
3-year earnings per share growth (CAGR)
-54.22%
What the Analysts think about Bausch Health
Analyst ratings (Buy, Hold, Sell) for Bausch Health stock.
Bausch Health Financial Performance
Revenues and expenses
Bausch Health Earnings Performance
Company profitability
Bausch Health News
AllArticlesVideos
Facial Injectable Market Forecasts Report 2025-2030, Competitive Analysis of Key Players - Allergan, Bausch Health, Bloomage Biotechnology, and Galderma
GlobeNewsWire·2 weeks ago
Bausch Health Announces 2025 Annual Meeting of Shareholder Results
Accesswire·3 weeks ago
Bausch + Lomb Receives European CE Mark Approval for Preloaded LuxLife® Full Range of Vision Intraocular Lens
Business Wire·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Bausch Health stock?
Bausch Health (BHC) has a market cap of $1.7B as of June 06, 2025.
What is the P/E ratio for Bausch Health stock?
The price to earnings (P/E) ratio for Bausch Health (BHC) stock is 0 as of June 06, 2025.
Does Bausch Health stock pay dividends?
No, Bausch Health (BHC) stock does not pay dividends to its shareholders as of June 06, 2025.
When is the next Bausch Health dividend payment date?
Bausch Health (BHC) stock does not pay dividends to its shareholders.
What is the beta indicator for Bausch Health?
Bausch Health (BHC) has a beta rating of 0.43. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.